[HTML][HTML] CCR4 as a therapeutic target for cancer immunotherapy
O Yoshie - Cancers, 2021 - mdpi.com
Simple Summary CCR4 is a chemokine receptor selectively expressed on normal T cell
subsets such as type 2 helper T cells, skin-homing T cells and regulatory T cells, and on skin …
subsets such as type 2 helper T cells, skin-homing T cells and regulatory T cells, and on skin …
[PDF][PDF] CCR4 as a Therapeutic Target for Cancer Immunotherapy. Cancers 2021, 13, 5542
O Yoshie - 2021 - pdfs.semanticscholar.org
CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
CCR4 as a Therapeutic Target for Cancer Immunotherapy
O Yoshie - Cancers, 2021 - search.proquest.com
CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
CCR4 as a Therapeutic Target for Cancer Immunotherapy
O Yoshie - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
CCR4 as a Therapeutic Target for Cancer Immunotherapy.
O Yoshie - Cancers, 2021 - search.ebscohost.com
Simple Summary: CCR4 is a chemokine receptor selectively expressed on normal T cell
subsets such as type 2 helper T cells, skin-homing T cells and regulatory T cells, and on skin …
subsets such as type 2 helper T cells, skin-homing T cells and regulatory T cells, and on skin …
CCR4 as a Therapeutic Target for Cancer Immunotherapy
O Yoshie - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor
for two CC chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was …
for two CC chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was …
[HTML][HTML] CCR4 as a Therapeutic Target for Cancer Immunotherapy
O Yoshie - Cancers, 2021 - ncbi.nlm.nih.gov
CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
CCR4 as a Therapeutic Target for Cancer Immunotherapy.
O Yoshie - Cancers, 2021 - europepmc.org
CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …
chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described …